Purchase Order HHSN269201700526P
Award Date 7/19/17
Potential Completion Date 9/19/23
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a manufacturer of in vitro diagnostic reagents, test kits, and related equipment for blood transfusion and transplantation compatibility testing. The contract, valued at $15,655.11, is a firm-fixed-price order issued under Immucor's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract does...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price purchase order for $16,566.11 to Immucor Inc. to fulfill a requirement for reagents. The contract has no set-aside designation and is to be completed by September 30, 2024. Immucor is a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. This award positions Immucor to directly supply specialized...
- This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The $19,938.86 firm fixed-price delivery order is for the supply of REAGENTS under Immucor's existing General Services Administration (GSA) Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits. This award does...
- This is a federal contract award made by the National Institutes of Health (NIH) to Immucor Inc., a for-profit manufacturer of goods. The contract is a delivery order issued under Immucor's existing General Services Administration (GSA) Federal Supply Schedule (FSS) contract for in vitro diagnostics, reagents, and testing supplies. The order is for $15,545.99 on a firm fixed price basis. Immucor has provided a variety of blood banking and transfusion diagnostic products and services to federal...
- This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
- This federal contract was awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for blood transfusion and transplantation testing. The contract, valued at $209,111.24, is for the delivery of CLIN reagents and supplies. It is a firm fixed-price Blanket Purchase Agreement (BPA) call order with a completion date of March 13, 2019. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related...
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Immucor Inc. on February 7, 2018, valued at $4,970.47, with completion on March 7, 2018. The order carries no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order is firm fixed price for in vitro diagnostic products, reagents, or blood banking supplies supporting federal healthcare operations.</p>
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 9 (VISN 9) of the U.S. Department of Veterans Affairs (VA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The $14,767.48 contract is for the delivery of Immucor blood products to support the VA's blood transfusion and transplantation compatibility testing requirements. Immucor has a history of providing specialized reagents, blood analyzers, and related consumables to federal...
- This firm fixed-price federal contract award to Immucor Inc. is for the provision of in-vitro diagnostic substances and related manufacturing services. The $20,000.00 contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense, and has an ultimate completion date of September 30, 2022. The award does not have a set-aside designation. Immucor Inc. is a for-profit manufacturer specializing in automated blood testing equipment, reagents, and consumables for...